Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) is very pleased to announce the closing of the over-subscribed second and final tranche of its previously announced non-brokered private placement. Further to its press release, dated March 16th, 2018, the Company closed the second tranche for gross proceeds of $1,726,754. through the issuance of 1,996,247 Units.

The non-brokered Private Placement had been originally announced as being comprised of 3,000,000 Units for total proceeds of $2,595,000. The closing numbers today reflect an increase of 3,545,007 Units for a total of $3,066,434.

The Company will pay an aggregate cash finder’s fee of $82,632. and issue an aggregate of 95,529 finders’ warrants. Each non-transferable finder’s warrant entitles the finder to acquire one common share at $0.87 for 14 months from the closing of the private placement.

Each Unit consists of one common share and one common share purchase warrant. Each transferable whole common share purchase warrant will entitle the holder to acquire one common share at $0.87. The Purchase Warrants may be exercised at any time until 12 months from the closing of the private placement.

All securities issued pursuant to this financing will be subject to resale restrictions for a period of four months and one day from closing under applicable securities legislation.

The net proceeds raised from the Unit Offering are intended to be used for further development of the Company’s projects in Las Vegas, Nevada  Washington State, Desert Hot Springs, California and general corporate purposes.

ABOUT MARAPHARM VENTURES INC.

Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.